Phospholipases

Phosphatidylinositol 4,5-bisphosphate serves as a critical substrate for phospholipase C, facilitating the production of diacylglycerol and inositol (1,4,5)-trisphosphate. This phospholipid is predominantly located in the cytoplasmic leaflet of the plasma membrane and plays a pivotal role in cellular processes such as lamellipodial protrusion, directional cell migration, and focal adhesion formation. Additionally, it is involved in the trafficking of GABAA receptors. Phosphatidylinositol 4,5-bisphosphate is relevant for research focusing on acute lung injury and pulmonary edema.

Cinatrin C2 is a potent inhibitor of phospholipase A2 (PLA2) with an IC50 of 800 μM. This compound, sourced from Circinotrichum falcatisporum RF-641, is valuable for studying PLA2's role in various biological processes. It is applicable in research areas related to inflammation, pain mechanisms, and cellular signaling pathways.

ASM-IN-3 is a selective inhibitor of acid sphingomyelinase (ASM) with a reported IC50 of 3.37 μM for human ASM. This compound demonstrates the ability to penetrate the blood-brain barrier and has been shown to enhance neurogenesis in the hippocampus, alleviating depression-like behaviors in Reserpine-induced rat models. ASM-IN-3 serves as a valuable tool for research in neurobiology and the treatment of mood disorders.

Cinatrin C3 is a selective phospholipase A2 (PLA2) inhibitor, exhibiting an IC50 value of 70 μM. This compound is derived from the marine fungus Circinotrichum falcatisporum RF-641. Cinatrin C3 is utilized in research to explore the functional roles of PLA2 in various biological processes, including inflammation and cellular signaling pathways. Its inhibitory properties make it a valuable tool for studying the mechanistic functions of PLA2 in pathophysiological contexts.

VU0155056 is a selective inhibitor of phospholipase D, which plays a crucial role in lipid metabolism and signaling pathways. This compound demonstrates the ability to modulate phospholipase D activity, making it a valuable tool for investigating lipid-mediated cellular processes. Its applications include studying the regulation of membrane dynamics and the roles of phospholipase D in various biological contexts.

Cinatrin C1 is a selective phospholipase A2 (PLA2) inhibitor derived from the fungus Circinotrichum falcatisporum RF-641. This compound exhibits significant biological activity by modulating lipid metabolism and inflammatory processes. Cinatrin C1 serves as a valuable tool in biochemical research focused on elucidating the role of PLA2 in various physiological and pathological conditions.

HpFabZ-IN-1 is an inhibitor of the FabZ enzyme, which plays a crucial role in the fatty acid synthesis pathway of Helicobacter pylori. With an IC50 value of 39.8 µM, this compound is primarily utilized in research investigating fatty acid biosynthesis and related metabolic pathways in H. pylori. Although it does not exhibit antibacterial activity, HpFabZ-IN-1 serves as an important tool for studying the molecular mechanisms underlying this pathogenic bacterium.

ARF1 (2-17) is a selective inhibitor of phospholipase D (PLD) and phospholipase C-β (PLC-β), targeting both ARF-dependent and ARF-independent signaling pathways. This compound effectively inhibits GTP-γ-S-stimulated PLD activity, thereby playing a crucial role in modulating exocytosis and related cellular processes. Its application in research includes studying lipid signaling and the regulation of membrane traffic in cellular models.

Cinatrin B is a potent inhibitor of phospholipase A2, an enzyme involved in the hydrolysis of phospholipids, leading to the release of arachidonic acid and the subsequent production of inflammatory mediators. This compound demonstrates significant biological activity in modulating inflammatory responses and has potential applications in research related to inflammation and related diseases. Its ability to selectively inhibit phospholipase A2 makes Cinatrin B a valuable tool for studying lipid metabolism and signaling pathways in various biological systems.

Ro 31-4639 is a potent inhibitor of phospholipase A2, displaying an IC50 of 1.5 μM. This compound is valuable for studying the role of phospholipase A2 in inflammatory processes and membrane biochemistry. Its inhibitory activity makes it a critical tool in investigating pathways related to lipid metabolism and the modulation of arachidonic acid release.

AK106-001616 is a selective inhibitor of cytosolic phospholipase A2 (cPLA2), exhibiting a potent inhibition with an IC50 of 3.8 nmol/L. This compound effectively reduces the synthesis of pro-inflammatory mediators, including prostaglandins E2 and leukotrienes B4, in stimulated cells. AK106-001616 is valuable for research into inflammatory diseases, neuropathic pain, and pulmonary fibrosis, providing insights into the modulation of inflammatory pathways.

Hispidospermidin is a selective inhibitor of phospholipase C, a key enzyme involved in various signal transduction pathways. This compound exhibits significant biological activity by modulating intracellular calcium signaling and inositol phosphate metabolism. Its potential applications in research include studying cellular signaling mechanisms and investigating diseases related to dysregulated phospholipase C activity.

Darapladib analog-1 is an O-alkylated derivative of Darapladib that specifically targets lipoprotein-associated phospholipase A2 (Lp-PLA2). This compound exhibits potent inhibitory activity against Lp-PLA2, making it a valuable reagent for studying the pathophysiology of atherosclerosis. Researchers can utilize Darapladib analog-1 to explore its therapeutic potential in cardiovascular disease development and progression.

ARC39 is a selective inhibitor of acid sphingomyelinase (ASM), a key enzyme involved in sphingolipid metabolism. By inhibiting ASM, ARC39 modulates sphingolipid levels, which play critical roles in cellular signaling and stress responses. Its biological activity makes it a valuable tool for research related to neurodegenerative diseases, cancer, and inflammation, facilitating the exploration of sphingolipid-related pathways in various cellular contexts.

DPTIP hydrochloride is a selective inhibitor of neutral sphingomyelinase 2 (N-SMase 2), exhibiting an IC50 of 30 nM. This compound is known for its ability to penetrate the blood-brain barrier, making it a valuable tool for studying exosome-mediated cellular processes. Research applications include investigations into neurodegenerative diseases and the role of sphingosine metabolism in cellular signaling pathways.

Methyl γ-linolenyl fluorophosphonate (MγLnFP) is an analog of the well-known irreversible phospholipase inhibitor, methyl arachidonyl fluorophosphonate (MAFP). This compound serves as a potent tool for investigating the mechanisms of phospholipase activity and regulation. Its specificity for phospholipases makes it valuable in research applications focused on cell signaling, inflammation, and membrane phospholipid metabolism.

Sphingolactone-24 is a selective and irreversible inhibitor of neutral sphingomyelinase (nSMase). This compound is significant in biological research due to its ability to modulate sphingolipid metabolism, which plays a critical role in various cellular processes. Sphingolactone-24 is particularly useful in studies related to acute lung injury, enabling researchers to explore therapeutic interventions in respiratory conditions associated with nSMase activity.

GK470 is a potent inhibitor of group IVA cytosolic phospholipase A2 (GIVA cPLA2) with an IC50 of 300 nM in vesicle assays. This compound exhibits significant anti-inflammatory activity by inhibiting the release of arachidonic acid in SW982 fibroblast-like synoviocytes, with an IC50 of 0.6 μM. GK470 demonstrates comparable anti-inflammatory effects to conventional therapies in models of arthritis and effectively reduces plasma PGE2 levels, making it a valuable tool for researching inflammatory pathways and potential therapeutic interventions.

DPPI-4,5-P2 ammonium is a substrate for Phosphoinositide-specific phospholipase C-δ1 (PI-PLC-δ1), an enzyme critical in phosphoinositide signaling pathways. This compound is essential for studying the catalytic activity of PI-PLC-δ1 and its role in various cellular processes, including signal transduction and membrane remodeling. It serves as a valuable tool in biochemical assays and research focused on phosphoinositide metabolism.